RxDoctor Payments Data

Philip Ilaria

Neurology · Red Bank, NJNPI 1235105081

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novartis at 28.8% of the total. Reporting peaked in 2019 at $390 and has fallen 81.3% since, to $73 in 2021. That places this record below the midpoint for neurology clinicians in NJ, where the typical reported total is $1,560.

$825in general payments, 2019–2025

Across 63 payments — averaging $13.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$238
  • UCB, Inc.$66
  • Biogen$64
  • EMD Serono, Inc.$56
  • AbbVie$41
  • AstraZeneca$37
  • plus $323 from 16 others

What the payments were for

  • Speaking & faculty fees$111%
  • Food & beverage$79196%
  • Education$233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$825 in reported general payments places this provider in the 40th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey →

Other neurology in Red Bank

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →